Skip to content

Effect of Exercise on the Disease Activity of Rheumatoid Arthritis

Evaluation of the Effect of Exercise on Disease Activity and Immune Parameters in Persons With Rheumatoid Arthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00792675
Acronym
RA&Ex
Enrollment
55
Registered
2008-11-18
Start date
2003-01-01
Completion date
2006-11-01
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

exercise, disease activity, inflammation, resistance training, rehabilitation

Brief summary

This study will evaluate the effect of exercise on the number of swollen and tender joints associated with rheumatoid arthritis after a 12 week exercise program of treadmill walking and weightlifting.

Detailed description

The goal of this study was to evaluate the effect of exercise on the number of swollen and tender joints associated with rheumatoid arthritis. It was hypothesized that persons would have less inflammation associated with rheumatoid arthritis after a 12 week exercise program of treadmill walking and weighlifting. Immune parameters were measured to determine potential mechanisms responsible for changes in inflammation with exercise.

Interventions

Exercise was performed 3 times per week. It consisted of 30 minutes of treadmill exercise at approximately 85% of heartrate max and 2 sets of 6 resistance weight lifting exercises resulting in volitional fatigue at 12 to 15 repetitions.

Sponsors

Arthritis Foundation
CollaboratorOTHER
Nebraska Chapter Arthritis Foundation
CollaboratorUNKNOWN
University of Nebraska
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* a diagnosis of RA according to the ACR 1989 Criteria at least 6 months prior to enrollment in the study, but not longer than 12 years * age 19 to 65 years old * stable regimen of medication for 2 months with less than 10 mg/day of oral corticosteroids * currently exercise \< 2x/week for less than 30 minutes at less than 60% of his/her age predicted maximum heart rate * Subjects must pass the Physical Activity Readiness Scale Questionnaire (PAR-Q)

Exclusion criteria

* other serious health problems * intra-articular injection within 6 weeks * total joint replacement of the large joints * use of beta-blockers * inability to complete the submaximal exercise test

Design outcomes

Primary

MeasureTime frame
Swollen Joint Count12 Weeks
Tender Joint Count12 Weeks

Secondary

MeasureTime frame
Practitioner Global Assessment12 Weeks
Timed-Stands Test12 Weeks
Pain (visual Analog Scale)12 Weeks
50 Foot Walk Test12 Weeks
Estimated Aerobic Capacity (VO2max)12 weeks
SF-3612 Weeks
Modified-Health Assessment Questionnaire12 Weeks
Patient Global Assessment12 Weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026